Eleonora Ortu1, Davide Pietropaoli2, Samuele Cova3, Maria Chiara Marci2, Annalisa Monaco2. 1. MeSVA Department, Dental Unit, University of L'Aquila, P.Le S. Tommasi, 67100, L'Aquila, Italy. eleortu@gmail.com. 2. MeSVA Department, Dental Unit, University of L'Aquila, P.Le S. Tommasi, 67100, L'Aquila, Italy. 3. Cova Samuele, DDS, Freelance, 38023, Cles, Trento, Via Tiberio Claudio, Italy.
Abstract
BACKGROUND: This study aimed to verify the efficacy of two elastodontic devices in overjet (OJ) and overbite (OB) reduction during treatment with the Equilibrator Series II (Eptamed) and Occlus-o-Guide (Sweden & Martina) devices. METHOD: Sixty patients aged 7-15 years were enrolled in the study, and were divided into test and control groups. The test group included 30 patients (14 males, 16 females; mean age, 10.66 ± 2.12 years) treated with the EQ (Equilibrator) Series II. The control group included 30 patients (15 males, 15 females; mean age, 10.76 ± 2.52 years) treated with the Occlus-o-Guide. The two groups exhibited the same orthodontic features. The orthodontic criteria were: skeletal and dental class II malocclusion (divisions 1 and 2); and the presence of OJ and OB. Evaluation of OJ and OB was performed at two timepoints: T0 (before starting therapy) and T1 (after 1 year). RESULTS: At T0, OJ and OB were similar for the two groups; however, at T1, both OJ and OB were significantly lower with the Eptamed device compared to the Occlus-o-Guide device (p = 0.0019). CONCLUSIONS: Elastodontic devices improve orthodontic outcomes by aiding orthodontic patient management, diagnosis, and treatment planning, reducing the risk relapse acting on the whole organism and the rehabilitation of the tongue.
BACKGROUND: This study aimed to verify the efficacy of two elastodontic devices in overjet (OJ) and overbite (OB) reduction during treatment with the Equilibrator Series II (Eptamed) and Occlus-o-Guide (Sweden & Martina) devices. METHOD: Sixty patients aged 7-15 years were enrolled in the study, and were divided into test and control groups. The test group included 30 patients (14 males, 16 females; mean age, 10.66 ± 2.12 years) treated with the EQ (Equilibrator) Series II. The control group included 30 patients (15 males, 15 females; mean age, 10.76 ± 2.52 years) treated with the Occlus-o-Guide. The two groups exhibited the same orthodontic features. The orthodontic criteria were: skeletal and dental class II malocclusion (divisions 1 and 2); and the presence of OJ and OB. Evaluation of OJ and OB was performed at two timepoints: T0 (before starting therapy) and T1 (after 1 year). RESULTS: At T0, OJ and OB were similar for the two groups; however, at T1, both OJ and OB were significantly lower with the Eptamed device compared to the Occlus-o-Guide device (p = 0.0019). CONCLUSIONS: Elastodontic devices improve orthodontic outcomes by aiding orthodontic patient management, diagnosis, and treatment planning, reducing the risk relapse acting on the whole organism and the rehabilitation of the tongue.
Authors: E Ortu; G Barrucci; G Aprile; L Guerrini; D Pietropaoli; A Monaco Journal: J Biol Regul Homeost Agents Date: 2020 Sep-Oct Impact factor: 1.711
Authors: M M Grippaudo; V Quinzi; A Manai; E G Paolantonio; F Valente; G La Torre; G Marzo Journal: Eur J Paediatr Dent Date: 2020-09 Impact factor: 2.231
Authors: Alessio Danilo Inchingolo; Assunta Patano; Giovanni Coloccia; Sabino Ceci; Angelo Michele Inchingolo; Grazia Marinelli; Giuseppina Malcangi; Valentina Montenegro; Claudia Laudadio; Chiara Di Pede; Mariagrazia Garibaldi; Zamira Kruti; Maria Elena Maggiore; Antonio Mancini; Ludovica Nucci; Ioana Roxana Bordea; Antonio Scarano; Felice Lorusso; Gianna Dipalma; Daniela Di Venere; Filippo Cardarelli; Francesco Inchingolo Journal: Int J Environ Res Public Health Date: 2022-01-16 Impact factor: 3.390